Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study Meeting Abstract

  

Authors:	Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; Lahoud, O.; Usmani, S.; Landgren, O.; Lesokhin, A.
Abstract Title:	Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study
Meeting Title:	19th International Myeloma Society Annual Meeting (IMS)
Journal Title:	Clinical Lymphoma, Myeloma and Leukemia
Volume:	22
Issue:	Suppl.
Meeting Dates:	2022 Aug 25-27
Meeting Location:	Los Angeles, CA
ISSN:	2152-2650
Publisher:	Elsevier Inc.
Date Published:	2022-08-01
Start Page:	S60
End Page:	S61
Language:	English
ACCESSION:	WOS:000895909200104
PROVIDER:	wos
DOI:	10.1016/S2152-2650(22)00376-7
Notes:	Meeting Abstract: P-046 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/205231